N.C. Gov. Cooper: Leading Cell Therapy Biotech Company Chooses Research Triangle for Its North American R&D and Manufacturing Facility
May 22, 2021
May 22, 2021
RALEIGH, North Carolina, May 22 -- Gov. Roy Cooper, D-North Carolina, issued the following news release:
CARsgen Therapeutics Corporation, an innovative biotechnology company pursuing medicines to treat cancer will create approximately 200 jobs and invest $157 million in Durham, Governor Roy Cooper announced today. The company's selection of the Research Triangle area will establish its first biomanufacturing site in North America. CARsgen Therapeutics currently has its U.S. clinica . . .
CARsgen Therapeutics Corporation, an innovative biotechnology company pursuing medicines to treat cancer will create approximately 200 jobs and invest $157 million in Durham, Governor Roy Cooper announced today. The company's selection of the Research Triangle area will establish its first biomanufacturing site in North America. CARsgen Therapeutics currently has its U.S. clinica . . .